Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:PPLPHARMAHealthcare
Clear all filters
NEWS
positive
Google News - Investing.com India 64d ago

Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy - Investing.com India

Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI StrategyInvesting.com India

PPLPHARMAPTCPTCILTANLACapital GoodsHealthcare
Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy - Investing.com India
positive
Google News - India Markets 64d ago

Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy - Investing.com India

Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI StrategyInvesting.com India

PPLPHARMAPTCPTCILTANLACapital GoodsHealthcare
Q4 Results Highlights: CEAT profit jumps 144%; Go Digit General Insurance profit up 29%
positive
CNBC TV18 - Markets 73d ago

Q4 Results Highlights: CEAT profit jumps 144%; Go Digit General Insurance profit up 29%

Q4 Results LIVE Updates: It is an important day today with regards to results, as India's largest passenger car manufacturer, Maruti Suzuki India Ltd., and food delivery-to-quick commerce operator Eternal, will be reporting results today. Besides these, there are plenty of broader market names, such as Bandhan Bank, Sapphire Foods, Castrol India, CEAT, Star Health, Piramal Pharma, REC, Motherson Sumi Wiring, Sanofi India, Sanofi Consumer Health, Leela Palace Hotels and many others will be reporting their results today. Watch this space for all the LIVE updates.

ALLETECBANDHANBNKBANKINDIACASTROLINDCEATLTDCONSUMERETERNALGICREGODIGITICICIGILTFOODSMARUTIMEDANTAMOTHERSONMSUMINIVABUPAPPLPHARMARECLTDSANOFISANOFICONRSAPPHIRESTARSTARHEALTHTHELEELAAutomobile and Auto ComponentsConsumer Services
Piramal Pharma receives USFDA EIR for US facility; inspection closed with VAI
positive
CNBC TV18 - Markets 89d ago

Piramal Pharma receives USFDA EIR for US facility; inspection closed with VAI

Piramal Pharma gets USFDA EIR with VAI for its Lexington plant, closing the 2025 inspection, shares edge up though stock remains 34% down over the past year.

PPLPHARMAHealthcare
Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers
negative
LiveMint - Markets 121d ago

Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers

The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.

AONETMMQ50AONETOTALAPOLLOAPOLLOTYREAUTOBEESAUTOIETFFMNLGROWWCAPMMOCAPITALPGELPHARMABEESPPLPHARMASDL26BEESTEJASNETTOP10ADDTOP15IETFTOP20Automobile and Auto ComponentsCapital Goods
NEWS
negative
Business Standard - Markets 121d ago

Tejas Networks Ltd leads losers in 'A' group

Piramal Pharma Ltd, Northern ARC Capital Ltd, IndusInd Bank Ltd and Amber Enterprises India Ltd are among the other losers in the BSE's 'A' group today, 12 March 2026.

AMBERBANKINDIABSECAPITALSFBCPCAPECAPINSUREINDUSINDBKNORTHARCPPLPHARMASBIBPBTEJASNETConsumer DurablesFinancial Services
Buy or sell: Vaishali Parekh recommends three stocks to buy today — 11 March 2026
positive
LiveMint - Markets 122d ago

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 11 March 2026

Buy or sell stocks: Vaishali Parekh recommends three stocks to buy today — Piramal Pharma, Bharat Dynamics, and Oberoi Realty

BDLOBEROIRLTYPPLPHARMAVAISHALICapital GoodsHealthcare
Piramal Pharma shares gain over 3% as US FDA closes inspection at Sellersville facility
positive
Moneycontrol NaNd ago

Piramal Pharma shares gain over 3% as US FDA closes inspection at Sellersville facility

A successful closure of a US FDA inspection is generally viewed positively by investors as it removes a key regulatory overhang

PPLPHARMAHealthcare
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Piramal Pharma; target of Rs 190: Motilal Oswal

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPPLPHARMASPARCFinancial ServicesHealthcare
Prev
1